NIH-funded research NIH-funded research

Understanding how small heat shock proteins protect our cells

Official title: Understanding Small Heat Shock Protein Mechanism

Funded at University of Washington · NIH-11609397 · Data updated 2026-11-12

A study from the University of Washington explores how tiny chaperone proteins protect eye and other cells from damage, which could help prevent conditions like cataracts and age-related macular degeneration.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startMay 1, 2007
Project endAugust 31, 2028
Funding year2026
Award (this year)$1,339,248
NIH project number2R56EY017370-17A1
Project IDNIH-11609397 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals at risk for cataracts or age-related macular degeneration, or patients with related cellular protection or cytoskeletal issues.

Less likely to help

People without risk factors for these eye conditions may not directly benefit from this line of research.

What this research studies

Researchers are studying small heat shock proteins (sHSPs), especially HSPB5, to see how they guard the cell’s skeleton and prevent protein clumping. The work builds on new tools that reveal how these proteins form and function at a detailed level. By understanding how HSPB5 supports the cytoskeleton, the project aims to uncover how cells stay healthy under stress and how this protection might fail in aging-related eye diseases. The effort involves advanced experiments and analysis to map how sHSPs interact with cytoskeletal components and how mutations lead to disease.

Why it matters

Potential benefit: If successful, this work could lead to new strategies to prevent or treat cataracts and age-related macular degeneration by preserving cellular health.

How similar studies have gone: Previous findings show that sHSPs have protective roles in cells, suggesting this approach could yield meaningful insights, though the exact protective mechanisms are still being defined.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Klevit, Rachel E — University of Washington
  • Study coordinator: Klevit, Rachel E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.